II. Causes: General
- Malignancy
- Small Cell Lung Cancer (most common ectopic ADH source)
- Duodenal Cancer
- Pancreatic Cancer
- Head and neck cancers
-
Lung disease
- Bacterial Pneumonia
- Empyema
- Legionella pneumonia
- Pulmonary Tuberculosis
- Acute Respiratory Distress Syndrome (ARDS) or other Acute Respiratory Failure
- Neurologic disorders
- Miscellaneous causes
- Psychiatric illness
- Rocky Mountain Spotted Fever
- Hyponatremia is common in this uncommon Tick Borne Illness
- Post-operative period
- Young women have postoperative ADH levels 40x higher than postmenopausal women
- Young women are at higher risk of postoperative hyponatremic encephalopathy
III. Causes: Medications
- Cardiovascular agents
- Neuropsychiatric agents
-
Analgesics
- Morphine Sulfate and other Opioids
- NSAIDs
- Chemotherapeutic agents
- Vinca alkaloids (e.g. Vincristine)
- Platinum Chemotherapy (e.g. Cisplatin)
- Other Alkylating Agents (e.g. Cyclophosphamide)
- Miscellaneous agents
- Sulfonylureas
IV. Differential Diagnosis
- SIADH is a diagnosis of exclusion
- Isovolemic Hypoosmolar Hyponatremia
- Non-osmotic causes for ADH secretion
- Causes of Decreased urine diluting capacity
V. Symptoms
VI. Labs
- Hyponatremia
-
Urine Osmolality > 100 mOsm/kg water
- Dilution not maximized despite serum hypoosmolality
- Urine Sodium > 20-30 mEq/L
- Serum Osmolality decreased <280 mOsm
- Hypouricemia (Serum Uric Acid <4 mg/dl)
- Antidiuretic Hormone (ADH) elevated
VII. Management
- Treating underlying cause is key in SIADH
- Example: Treat underlying Bronchogenic Carcinoma
- Relevant Consultation (e.g. oncology, nephrology)
- Overall strategy
- See Isovolemic Hypoosmolar Hyponatremia
- Fluid restriction (<1000 to 1500 ml/day)
- Diuretics
- Slow Serum Sodium correction
- See Hyponatremia Management
- Do not correct more quickly than 12 mEq/L in 24 hours or 18 mEq/L in 48 hours
- Avoid Normal Saline infusion
- May worsen Hyponatremia with Fluid Shifts intravascularly
- SIADH refractory to above measures
- Induce Nephrogenic Diabetes Insipidus
- Demeclocycline (600-1200 mg/day)
- Lithium Carbonate 300 mg PO tid
- Tolvaptan (Samsca)
- Selective Vasopressin (V2) receptor Antagonist
- Increases free water excretion
- Adverse effects: Hepatotoxin
VIII. References
- Le and Drogell (2015) Crit Dec Emerg Med 29(11): 13-19
- Kone in Tisher (1993) Nephrology, p. 87-100
- Levinsky in Wilson (1991) Harrison's IM, p. 281-84
- Preston (2011) Acid-Base, Fluids and Electrolytes, Medmaster, Miami
- Rose (1989) Acid-Base and Electrolytes, p. 601-38
- Goh (2004) Am Fam Physician 69:2387-94 [PubMed]
- Higdon (2018) Am Fam Physician 97(11):741-8 [PubMed]
- Braun (2015) Am Fam Physician 91(5): 299-307 [PubMed]